The LAMEA infusion therapy devices market is anticipated to grow at a CAGR of more than 6.5% during the forecast period. The prevalence of chronic diseases including diabetes and cancer are high in the region however lack of awareness, poor healthcare infrastructure in African countries, and low healthcare expenditure are some of the major factors for the small market in the region. According to IDF, the prevalence rate of diabetes in Latin America is projected to increase by 62%, increasing from 26 million cases in 2017 to 42 million in 2045. Brazil and Mexico are the two countries with a high number of diabetes cases registered.
Visit for Global Infusion Therapy Devices Market Report at: https://www.omrglobal.com/industry-reports/infusion-therapy-devices-market-size
The LAMEA infusion therapy devices market is segmented on the basis of product type, application, and end-user. Based on the product type, the market is classified into infusion pumps and consumables & accessories. Based on the application, the market is segregated into oncology, diabetes, gastroenterology, analgesia, hematology, and others. The end-user segment is classified into hospitals, home care, and ambulatory surgery centers.
The major players contributing to the growth of the LAMEA infusion therapy devices market include B. Braun Melsungen AG, Medtronic PLC, Novartis AG, and Terumo Corp. The players operating in the market adopt various strategies such as technology development, product launch, merger and acquisitions for gaining a sustainable position in the market that further propels the growth of the market.
Research Methodology
The market study of the LAMEA infusion therapy devices market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.
Secondary Sources Include
The report is intended for medical device manufacturers, academic and government research institutes, food and agriculture industries, potential investors and venture capitalists, and other market participants for overall market analysis and competitive analysis. The report provides an in-depth analysis of market size, products offered by the company, and future market opportunities. The report will serve as a source for a 360-degree analysis of the market thoroughly delivering insights into the market for making better business decisions.
Market Segmentation
1. LAMEA Infusion Therapy Devices Market Research and Analysis by Product
2. LAMEA Infusion Therapy Devices Market Research and Analysis by End-User
3. LAMEA Infusion Therapy Devices Market Research and Analysis by Application
The Report Covers
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. LAMEA Infusion Therapy Devices Market by Product Type
5.1.1. Infusion Pumps
5.1.2. Consumables & Accessories
5.2. LAMEA Infusion Therapy Devices Market by Application
5.2.1. Oncology
5.2.2. Diabetes
5.2.3. Gastroenterology
5.2.4. Analgesia
5.2.5. Hematology
5.2.6. Others (Pediatrics)
5.3. LAMEA Infusion Therapy Devices Market by End-User
5.3.1. Hospitals
5.3.2. Homecare
5.3.3. Ambulatory Surgery Centers
6. Regional Analysis
6.1. Brazil
6.2. Argentina
6.3. UAE
6.4. Kenya
6.5. South Africa
6.6. Nigeria
6.7. Rest of LAMEA
7. Company Profiles
7.1. B. Braun Melsungen AG
7.2. Baxter International, Inc.
7.3. Becton, Dickinson and Co.
7.4. Caesarea Medical Electronics Ltd.
7.5. Fresenius SE & Co. KGaA
7.6. Johnson & Johnson Services, Inc.
7.7. Medtronic PLC
7.8. Novartis AG
7.9. Smith’s Group PLC
7.10. Terumo Corp.
1. LAMEA INFUSION THERAPY MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)
2. LAMEA INFUSION THERAPY MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2018-2025 ($ MILLION)
3. LAMEA INFUSION THERAPY MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)
4. LAMEA INFUSION THERAPY MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2018-2025 ($ MILLION)
1. LAMEA INFUSION THERAPY MARKET SHARE BY END-USER, 2018 VS 2025 (%)
2. LAMEA INFUSION THERAPY MARKET SHARE BY PRODUCT TYPE, 2018 VS 2025 (%)
3. LAMEA INFUSION THERAPY MARKET SHARE BY APPLICATION, 2018 VS 2025 (%)
4. LAMEA INFUSION THERAPY MARKET SHARE BY GEOGRAPHY, 2018 VS 2025 (%)
5. BRAZIL INFUSION THERAPY MARKET SIZE 2018-2025 ($ MILLION)
6. ARGENTINA INFUSION THERAPY MARKET SIZE 2018-2025 ($ MILLION)
7. UAE INFUSION THERAPY MARKET SIZE 2018-2025 ($ MILLION)
8. KENYA INFUSION THERAPY MARKET SIZE 2018-2025 ($ MILLION)
9. SOUTH AFRICA INFUSION THERAPY MARKET SIZE 2018-2025 ($ MILLION)
10. NIGERIA INFUSION THERAPY MARKET SIZE 2018-2025 ($ MILLION)
11. REST OF LAMEA INFUSION THERAPY MARKET SIZE 2018-2025 ($ MILLION)